efavirenz has been researched along with Weight Gain in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpomiemie, G; Denti, P; Griesel, R; Kawuma, AN; Maartens, G; Sinxadi, P; Sokhela, S; Venter, WDF; Wasmann, R; Wiesner, L | 1 |
| Hachey, D; Shiluama, R; Singu, BS; van Woerden, I | 1 |
| Baker, P; Basham, R; Bourgi, K; Bradford, Y; Cindi, Z; Daar, ES; Erdem, H; Gulick, R; Haas, DW; Hulgan, T; Koethe, J; Leonard, MA; Norwood, J; Rebeiro, PF; Riddler, SA; Ritchie, MD; Sinxadi, P; Sterling, TR; Turner, M; Woodward, B | 1 |
| Akpomiemie, G; Chirehwa, M; Griesel, R; Maartens, G; Moorhouse, M; Sinxadi, P; Sokhela, S; Venter, F | 1 |
| Burkholder, GA; Collier, AC; Crane, HM; Curtis, L; Delaney, JAC; Eron, JJ; Geng, E; Harding, BN; Henegar, C; Kitahata, MM; Lindström, S; Mathews, WC; Mayer, KH; Moore, RD; Nance, RM; Rodriguez, B; Ruderman, SA; Saag, MS; Van Wyk, J; Vannappagari, V; Whitney, BM; Willig, AL; Wood, BR | 1 |
| Chang, SC; Chang, SY; Chiang, C; Chuang, YC; Huang, SH; Huang, WC; Hung, CC; Kuo, PH; Lin, SW; Liu, WC; Sun, HY; Wu, PY | 1 |
| Bebawy, S; Bofill, C; Haas, DW; Hulgan, T; Koethe, JR; Norwood, J; Raffanti, S; Rebeiro, P; Shepherd, B; Sterling, TR; Turner, M | 1 |
| Boyer, S; Calmy, A; Delaporte, E; Eymard-Duvernay, S; Kouanfack, C; Leroy, S; Mpoudi-Etame, M; Omgba Bassega, P; Peeters, M | 1 |
3 trial(s) available for efavirenz and Weight Gain
| Article | Year |
|---|---|
Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.
Topics: Alkynes; Benzoxazines; Cyclopropanes; HIV Infections; HIV Integrase Inhibitors; Humans; Pharmacogenetics; Weight Gain | 2021 |
CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; Genotype; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Oxazines; Piperazines; Pyridones; Weight Gain | 2021 |
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.
Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Lamivudine; Male; Obesity; Oxazines; Piperazines; Pregnancy; Pyridones; RNA, Viral; Tenofovir; Viral Load; Weight Gain | 2019 |
5 other study(ies) available for efavirenz and Weight Gain
| Article | Year |
|---|---|
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Oxazines; Piperazines; Pyridones; Randomized Controlled Trials as Topic; Weight Gain | 2022 |
Weight gain in Namibians with HIV switching from efavirenz to dolutegravir.
Topics: Anti-HIV Agents; Benzoxazines; Emtricitabine; Female; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Male; Retrospective Studies; Tenofovir; Weight Gain | 2023 |
Brief Report: Weight Gain Following ART Initiation in ART-Naïve People Living With HIV in the Current Treatment Era.
Topics: Adult; Alanine; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Tenofovir; Weight Gain | 2021 |
Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; HIV Infections; HIV-1; Humans; Male; Prospective Studies; Retrospective Studies; Weight Gain | 2021 |
Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.
Topics: Adult; Alkynes; Benzoxazines; Cohort Studies; Cyclopropanes; Female; HIV Infections; HIV Integrase Inhibitors; Humans; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Weight Gain | 2017 |